GOLDMAN SACHS GROUP INC - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is TENX and the CUSIP is 88032L100. A total of 36 filers reported holding TENAX THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$54,000
-35.7%
26,266
+2.6%
0.00%
Q4 2015$84,000
+31.2%
25,611
+20.0%
0.00%
Q3 2015$64,000
-19.0%
21,337
-0.1%
0.00%
Q2 2015$79,000
+8.2%
21,360
-4.5%
0.00%
Q1 2015$73,000
-46.3%
22,366
-36.7%
0.00%
Q4 2014$136,000
-28.4%
35,347
-26.9%
0.00%
Q3 2014$190,00048,3530.00%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,108,593$3,326,0001.32%
RA Capital Management 2,670,300$8,011,0001.15%
Opaleye Management Inc. 635,000$1,905,0000.94%
Broadfin Capital, LLC 1,968,631$5,906,0000.33%
SABBY MANAGEMENT, LLC 2,604,660$7,892,0000.32%
DAFNA Capital Management LLC 81,509$245,0000.24%
ARMISTICE CAPITAL, LLC 88,739$266,0000.09%
BOURGEON CAPITAL MANAGEMENT LLC 17,500$52,0000.04%
Verition Fund Management LLC 25,640$78,0000.02%
COMMERZBANK AKTIENGESELLSCHAFT /FI 738,592$2,216,0000.02%
View complete list of TENAX THERAPEUTICS INC shareholders